Accretion Nutraveda Ltd vs SUN PHARMACEUTICAL IND L

A side-by-side comparison of Accretion Nutraveda Ltd (ACCRETIONNUTRAVEDALTD) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Accretion Nutraveda Ltd leads ACCRETIONNUTRAVEDALTD vs SUNPHARMA on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability22
  • Growth20
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ACCRETIONNUTRAVEDALTD takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
40.26
5.77
P/B ratio
20.07
0.00%
Dividend yield
0.84%
₹51.33
EPS
₹47.84

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

25.00%
Return on equity
16.00%
57.57%
Return on capital
21.00%
23.19%
EBITDA margin
30.00%
15.63%
Net margin
19.69%

Growth

ACCRETIONNUTRAVEDALTD takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

126.77%
Revenue CAGR (3Y)
10.03%
163.11%
Profit CAGR (3Y)
10.57%

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹205 Cr
Market cap
₹4.62L Cr
₹16 Cr
Revenue
₹58,462 Cr
₹3 Cr
Net profit
₹11,509 Cr
0.12
Debt / equity
0.61
Accretion Nutraveda Ltd
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 35.0%"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Debtor days have increased from 60.3 to 88.1 days.", "Working capital days have increased from 111 days to 196 days"]
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Accretion Nutraveda Ltd full analysis SUN PHARMACEUTICAL IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

ACCRETIONNUTRAVEDALTD vs SUNPHARMA: Share Price, Valuation & Which to Buy | DocStoX